/ /

Lynda Charters
Examining advances in EPI-ON CXL for keratoconus
Epithelial-on crosslinking seems to be effective and safe for treating keratoconus as the result of the combination of a new formulation of riboflavin with a higher level of ultraviolet light. This technique resulted in improvements in corneal shape, uncorrected visual acuity, and best spectacle-corrected visual acuity.
Managing MGD with thermal pulsation
A thermal pulsation system can safely and effectively treat meibomian gland obstructions in both the upper and lower eyelids simultaneously during an in-office procedure that takes only 12 minutes.
Inverted side cut has potential benefits in LASIK
Use of an inverted side cut when performing LASIK speeds recovery of corneal sensation.
Glaucoma therapy: cost effective, good return on investment
Value-based medicine analyses have indicated that glaucoma therapy has great patient benefits because it preserves their vision—which positively impacts their quality-of-life (QOL)—and it is cost effective with a high return on investment, according to Gary Brown, MD.
Endoscopy: The future of pituitary tumor treatment
Advances in endoscopy, a decades-old technology, offers major advantages to patients with pituitary tumors by improved visualization, rehabilitation, and shorter hospitalization.
New patient interface enhances laser refractive cataract surgery
A new patient interface improved the usability and performance of a femtosecond laser system in a multicenter study.
Novel laser platform aims to maximize incision accuracy, minimize damage
The VICTUS femtosecond laser platform (Bausch + Lomb) creates centered, round capsulotomies and should contribute greatly to the accuracy and predictability of cataract surgeries.
Cataract surgery: Perioperative intracameral antibiotics should be standard practice
Perioperative intracameral antibiotics should be standard practice during cataract surgery to prevent postoperative endophthalmitis.
Potential uses for collagen crosslinking
Collagen crosslinking (CXL) is currently used to treat keratoconus, pellucid marginal degeneration, and post-LASIK ectasia, although it has not yet received FDA approval. Thomas John, MD, discussed the potential of the technology to treat corneal infections.
Collagen CXL in young keratoconic patients
Collagen crosslinking (CXL) provides good results in young patients with keratoconus, but the key to success in these young patients is rapid treatment upon presentation without waiting for disease progression, said Paolo Vinciguerra, MD.

Poll

View Results